Comparison Between Two Hysteroscopic Biopsy Techniques in the Outpatient Setting for Sampling Hypotrophic or Atrophic Endometrium: 'Rail Biopsy' Versus 'Chip Biopsy'

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age48-75
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

Hysteroscopic endometrial biopsy is one of the most common procedures in gynecology. For patients with atrophic or hypotrophic endometrium, typical of menopausal women, the "chip biopsy" technique is often preferred as it provides adequate tissue samples for accurate histological examination. Recently, the "rail biopsy" technique has also been adopted at IRCCS AOUBO for biopsies in similar cases. Currently, the choice between these techniques depends largely on operator preference and experience, as there is no strong evidence favoring one over the other in terms of efficacy, safety, or tolerability.

This observational, single-center, cross-sectional, prospective, non-profit study aims to compare the procedure duration of "chip biopsy" versus "rail biopsy" in patients requiring endometrial biopsy of atrophic or hypotrophic endometrium. The study is expected to last approximately 14 months. Approximately 156 patients will be enrolled.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 48 years and ≤ 75 years

Women with atrophic endometrium, candidates for endometrial biopsy

Informed consent obtained for participation in the study and for the processing of personal data

Disqualifiers

Presence of intrauterine fibroids, polyps, and adhesions;

Current or recent (< 3 months) use of anticoagulant drugs and/or Selective Estrogen Receptor Modulators (SERMs);

Previous confirmed diagnosis of endometrial cancer;

Suspected active pelvic inflammation or history of recent pelvic inflammation (< 6 months);

Trial population

The recruitment of the study population will take place at the Hysteroscopy Outpatient Clinic of the Unit of Gynecology and Human Reproduction Physiopathology, IRCCS AOUBO. Patients referred to this clinic with an indication for diagnostic and/or operative hysteroscopy will undergo a thorough preliminary clinical evaluation to assess their eligibility for study enrollment (women with atrophic or hypotrophic endometrium requiring endometrial biopsy).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

To compare the duration of procedures performed using two different techniques for endometrial biopsy in patients requiring sampling of hypotrophic or atrophic endometrium: 'chip biopsy' and 'rail biopsy'

Time required to perform the hysteroscopic endometrial biopsy technique, measured in seconds from entry into the uterine cavity to completion of the procedure itself (excluding the time needed for removal of the resected tissue), during hysteroscopy

Time frame
During hysteroscopy

Secondary outcomes

1

To compare the safety of the procedure between the two endometrial biopsy techniques.

Adverse events (e.g., vasovagal syndromes, bleeding, uterine perforations, or other injuries to the uterus and surrounding organs)

Time frame
During hysteroscopy
2

To compare the adequacy of the tissue obtained for histological analysis between the two endometrial biopsy techniques.

Pathologist's assessment regarding specific factors (e.g., tissue quantity, absence of crushing and/or tearing and/or electrocautery artifacts and/or improper fixation)

Time frame
Upon delivery of the histological report (within 1 month from hysteroscopy)
3

To compare the need for additional accessory instruments between the two endometrial biopsy techniques.

Number of instruments used

Time frame
During hysteroscopy
4

Pain intensity assessed by Visual Analog Scale (VAS)

Pain intensity measured using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates worst possible pain.

Time frame
administered after hysteroscopy (within 24 hours)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.